Fig. 1From: Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancerStructure of AR-FL and AR-Vs and experimental workflow. A Shown are the coding sequences of AR-FL (exon 1–8) as well as AR-V 3, 7 and 9. B Overview of experimental design. Analyses were performed in cell lines, primary and metastatic tumor tissues, and clinical CTC samplesBack to article page